Chemomab Therapeutics (CMMB) Capital Expenditures (QoQ) (2018 - 2023)
Chemomab Therapeutics (CMMB) Capital Expenditures (QoQ) (2018 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Chemomab Therapeutics | 124.14 Mn | 113.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -500.00% |
| Mar 31, 2023 | -99.26% |
| Dec 31, 2022 | 421.43% |
| Sep 30, 2022 | -7.69% |
| Jun 30, 2022 | -378.57% |
| Mar 31, 2022 | -89.55% |
| Jun 30, 2021 | 3,300.00% |
| Mar 31, 2021 | 200.00% |
| Dec 31, 2020 | -95.00% |
| Sep 30, 2020 | 185.71% |
| Jun 30, 2020 | -30.00% |
| Mar 31, 2020 | -93.94% |
| Dec 31, 2019 | 202.48% |
| Sep 30, 2019 | -143.94% |
| Jun 30, 2019 | -142.04% |
| Mar 31, 2019 | -60.75% |
| Dec 31, 2018 | 549.44% |